UK company starts clinical trial on COVID-19

 

Steve Bates OBE, Chief Executive of the BIA said:

 

“The UK life science ecosystem is stepping up across the piece on coronavirus. It’s fantastic to see a small UK biotech company, Synairgen starting UK clinical trials immediately on Covid-19.

 

"This shows the speed at which our ecosystem can move; linking SMEs, the established UK clinical trials infrastructure of the NHS and an enabling regulator in the UK’s MHRA.

The sector is also working flat out on innovative emergent ventilator capacity, novel vaccine scale-up capacity, new ways to support NHS patients at home with digital products and investigating antibody technology for therapeutic use."

 

ENDS

Notes to Editors

1. For more information please contact Shannon Quinney, Communications Executive, on squinney@bioindustry.org or 07864902930

2. Read the press release by Synairgen here: https://www.synairgen.com/wp-content/uploads/2020/03/200318-Synairgen-to-start-trial-of-SNG001-in-COVID-19-imminently-.pdf